It is a trading private limited company based in Delhi, Delhi, India, established in 2021.
2021 | Delhi, Delhi, India | ActiveUpform Pharmaceuticals Private Limited, a active private limited company, was established on 17 December 2021 in Delhi, Delhi, India. Engaging in other wholesale within the trade sector, it holds CIN: U24299DL2021PTC391385. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Siva Kumar Appukuttan Sukesini (Managing Director), Manish Kumar (Director), Srishti Kumar (Director). Past directors included Sanskriti Kumar. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Rz-68 S/F Kh No-31 & 32, Gali No-6 Main Sagar Pur, Delhi, Delhi, 110046.
U24299DL2021PTC391385
391385
17 December 2021
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Upform Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Siva Kumar Appukuttan Sukesini | Managing Director | 28 Nov 2024 | Current |
| Manish Kumar | Director | 17 Dec 2021 | Current |
| Srishti Kumar | Director | 17 Dec 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 02 Jun 2025 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Upform Pharmaceuticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 4179.12% increase in profit. The company's net worth Soared by an impressive increase of 8079.12%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Upform Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Upform Pharmaceuticals has a workforce of 0 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Upform Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Upform Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Siva Kumar Appukuttan Sukesini was appointed as a Managing Director was appointed as a Managing Director on 28 Nov 2024 & has been associated with this company since 1 year 26 days . was completed.
Progress on Upform Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Upform Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
The activity Manish Kumar was appointed as a Director was appointed as a Director on 17 Dec 2021 & has been associated with this company since 4 years 7 days . was completed.
The activity Srishti Kumar was appointed as a Director was appointed as a Director on 17 Dec 2021 & has been associated with this company since 4 years 7 days . was completed.
Upform Pharmaceuticals Private Limited was registered on 17 Dec 2021 with Roc Delhi & aged 4 years 7 days as per MCA records. was recorded as a recent event.
The CIN of Upform Pharmaceuticals Private Limited is U24299DL2021PTC391385.
Upform Pharmaceuticals Private Limited is headquartered at Rz-68 S/F Kh No-31 & 32, Gali No-6 Main Sagar Pur, Delhi, Delhi, 110046.
Upform Pharmaceuticals Private Limited was incorporated on 17 December 2021.
The current directors of Upform Pharmaceuticals Private Limited are
The primary industry of Upform Pharmaceuticals Private Limited is Trade.
Upform Pharmaceuticals Private Limited is unlisted.
The authorized capital of Upform Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Upform Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX